# Lake Shore Bancorp, Inc.: financial statements, quarterly

LSBK · Nasdaq · CIK 2059653 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lsbk.md) · [Financials](/companies/lsbk/financials.md) · [Filings](/companies/lsbk/filings.md) · [Insiders](/companies/lsbk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lsbk/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Income tax | $k | not reported | [216](/filings/0000950170-25-107272.md) | [258](/filings/0001193125-25-277623.md) | [278 d](/filings/0001193125-26-109481.md) | [206](/filings/0001193125-26-219601.md) | [378](/filings/0001193125-26-344793.md) | [487](/filings/0001193125-25-277623.md) | [411 d](/filings/0001193125-26-109481.md) | [430](/filings/0001193125-26-219601.md) | [477](/filings/0001193125-26-344793.md) |
| Net income | $k | [1,014](/filings/0001193125-25-277623.md) | [1,116](/filings/0001193125-25-277623.md) | [1,332](/filings/0001193125-25-277623.md) | [1,469 d](/filings/0001193125-26-109481.md) | [1,057](/filings/0001193125-26-344793.md) | [1,919](/filings/0001193125-26-344793.md) | [2,359](/filings/0001193125-25-277623.md) | [1,934 d](/filings/0001193125-26-109481.md) | [1,923](/filings/0001193125-26-344793.md) | [2,173](/filings/0001193125-26-344793.md) |
| Diluted EPS | $ per share | not reported | [0.19](/filings/0000950170-25-107272.md) | [0.18](/filings/0001193125-25-277623.md) | not reported | [0.14](/filings/0001193125-26-219601.md) | [0.25](/filings/0001193125-26-344793.md) | [0.32](/filings/0001193125-25-277623.md) | not reported | [0.26](/filings/0001193125-26-219601.md) | [0.29](/filings/0001193125-26-344793.md) |
| Basic EPS | $ per share | not reported | [0.19](/filings/0000950170-25-107272.md) | [0.18](/filings/0001193125-25-277623.md) | not reported | [0.14](/filings/0001193125-26-219601.md) | [0.25](/filings/0001193125-26-344793.md) | [0.32](/filings/0001193125-25-277623.md) | not reported | [0.26](/filings/0001193125-26-219601.md) | [0.29](/filings/0001193125-26-344793.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [33.1](/filings/0001193125-26-109481.md) | not reported | [75.4](/filings/0000950170-25-107272.md) | [83.6](/filings/0001193125-25-277623.md) | [64.3](/filings/0001193125-26-344793.md) | [61.6](/filings/0001193125-26-219601.md) | [72.2](/filings/0001193125-26-344793.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [686](/filings/0001193125-26-109481.md) | not reported | [735](/filings/0000950170-25-107272.md) | [743](/filings/0001193125-25-277623.md) | [727](/filings/0001193125-26-344793.md) | [722](/filings/0001193125-26-219601.md) | [737](/filings/0001193125-26-344793.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [596](/filings/0001193125-26-109481.md) | not reported | [642](/filings/0000950170-25-107272.md) | [603](/filings/0001193125-25-277623.md) | [586](/filings/0001193125-26-344793.md) | [580](/filings/0001193125-26-219601.md) | [592](/filings/0001193125-26-344793.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [10.3](/filings/0001193125-26-109481.md) | not reported | [2.0](/filings/0000950170-25-107272.md) | [2.0](/filings/0001193125-25-277623.md) | [0.0](/filings/0001193125-26-109481.md) | not reported | not reported |
| Shareholders' equity | $m | [86.3](/filings/0001193125-26-109481.md) | [86.5](/filings/0001193125-25-277623.md) | [86.9](/filings/0001193125-25-277623.md) | [89.9](/filings/0001193125-25-277623.md) | [89.9](/filings/0001193125-26-344793.md) | [90.7](/filings/0001193125-26-344793.md) | [92.9](/filings/0001193125-26-344793.md) | [139](/filings/0001193125-25-277623.md) | [142](/filings/0001193125-26-344793.md) | [142](/filings/0001193125-26-344793.md) | [145](/filings/0001193125-26-344793.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,417) d](/filings/0001193125-25-277623.md) | [3,383 d](/filings/0001193125-26-109481.md) | [718](/filings/0001193125-26-219601.md) | [1,792 d](/filings/0001193125-26-344793.md) | [3,339 d](/filings/0001193125-25-277623.md) | [2,149 d](/filings/0001193125-26-109481.md) | [2,790](/filings/0001193125-26-219601.md) | [2,339 d](/filings/0001193125-26-344793.md) |
| Capital expenditure | $k | [0.0 d](/filings/0001193125-25-277623.md) | not reported | [150](/filings/0001193125-26-219601.md) | [386 d](/filings/0001193125-26-344793.md) | [41.0 d](/filings/0001193125-25-277623.md) | not reported | [8.0](/filings/0001193125-26-219601.md) | [80.0 d](/filings/0001193125-26-344793.md) |
| Dividends paid | $k | [361 d](/filings/0001193125-25-277623.md) | [360 d](/filings/0001193125-26-109481.md) | [361](/filings/0001193125-26-219601.md) | [0.0 d](/filings/0001193125-26-344793.md) | [658 d](/filings/0001193125-25-277623.md) | [657 d](/filings/0001193125-26-109481.md) | [662](/filings/0001193125-26-219601.md) | [663 d](/filings/0001193125-26-344793.md) |
| Share repurchases | $k | [0.0 d](/filings/0001193125-25-277623.md) | [3.0 d](/filings/0001193125-26-109481.md) | [35.0](/filings/0001193125-26-219601.md) | [16.0 d](/filings/0001193125-26-344793.md) | [0.0 d](/filings/0001193125-25-277623.md) | [2.0 d](/filings/0001193125-26-109481.md) | [32.0](/filings/0001193125-26-219601.md) | [50.0 d](/filings/0001193125-26-344793.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,886](/filings/0000950170-25-107272.md) | [7,640](/filings/0001193125-25-277623.md) | [7,656](/filings/0001193125-26-219601.md) | [7,682](/filings/0001193125-26-344793.md) | [7,395](/filings/0001193125-25-277623.md) | [7,365](/filings/0001193125-26-219601.md) | [7,394](/filings/0001193125-26-344793.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,853,788 at 2026-08-06, from the cover of the [10-Q filed 2026-08-11](/filings/0001193125-26-344793.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.